| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-1783 | |
| Phytochemical name or plant extracts | Tubeimu | |
| PMID | 22753707 | |
| Literature evidence | Tubeimu induced apoptosis of MDA-MB-231 cells, as observed by fluorescence microscopy, as early as 24 hours of treatment in vitro in two-dimensional culture. By 48 hours' treatment, DNA fragmentation could be observed. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | NA | |
| Source of phytochemicals or plant Extracts | Bolbostemma paniculatum | |
| Geographical availability | China North-Central, China South-Central, China Southeast, Inner Mongolia | |
| Plant parts | Tubers | |
| Other cancers | Breast cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | NA | |
| Potency | The results of the present study indicate the potential of tubeimu in breast cancer therapy. | |
| Cell line/ mice model | MDA-MB-231, SKBR-3 | |
| Additional information | Tubeimu has been shown to be active against nasopharyngeal carcinoma, cervical carcinoma, lung cancer , liver cancer , stomach cancer , colon cancer , and renal carcinoma. | |
| PubChem ID | NA | |
| Additional PMIDs | 26946628 | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:291523-1 | |
| Safety | NA |